Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
BAHCESEHIR UNIVERSITESI is managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between the 3 pending actions and the 3 distinct examiners indicates that each matter is being reviewed independently by a different specialist.
The busiest examiner for the university is SHIAO, YIH-HORNG, who is responsible for 1 pending office action. Since each of the 3 distinct examiners is handling only 1 action, the workload is evenly distributed across the portfolio. The involvement of 3 distinct art units suggests that the university's biotechnological research covers several different specialized fields.
With 3 pending office actions currently active, the university must coordinate its prosecution strategy across 3 different examiners. Each of the 3 distinct art units may have its own specific examination trends and requirements. Practitioners should be prepared to address the unique perspectives of SHIAO, YIH-HORNG and the other two examiners to advance these 3 pending actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIAO, YIH-HORNG | 1 | 72.6% | +75.9% |
| OBAID, HAMZEH M | 1 | 37.9% | +21.8% |
| MYERS, CARLA J | 1 | 49.5% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 26d overdue |
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 187d overdue |
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 26d overdue |
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 3624 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18722682 | RNA/DNA ISOLATION KIT WITH HIGH EFFICIENCY | SHIAO, YIH-HORNG | 1691 | §102§103§112 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18704489 | COMPUTERIZED WEIGHTED PROBLEM IMPACT SCORE CALCULATION SYSTEM AND A METHOD THEREOF | OBAID, HAMZEH M | 3624 | §101§102 | Final Rejection | 26d overdue | Pending | Apr 25, 2024 |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 1682 | §112 | Final Rejection | 187d overdue | Pending | Aug 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBAHCESEHIR UNIVERSITESI has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Yih-Horng Shiao has the most, with 1 of BAHCESEHIR UNIVERSITESI's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
